Cardiovascular

Irbefutal Co
  • Active Substance (s) : Irbesartan 150 mg + hydrochlorothiazide 12.5 mg - Irbesartan 300 mg + hydrochlorothiazide 12.5 mg
  • Dosage Form : Film Coated Tablets
  • Pack : 7 tablets/blister
  • Indication :
    • Treatment of essential hypertension
  • Product Description : Irbefutal Co is a combination of an angiotensin-II receptor antagonist, irbesartan, and a thiazide diuretic, hydrochlorothiazide The combination of these ingredients has an additive antihypertensive effect.
  • Recommended Daily Dosage :
    • Irbefutal Co can be taken once daily, with or without food